Teicoplanin: Clinical Trials

8 trials of Teicoplanin, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

4 completed, 2 terminated, 1 not yet recruiting, 1 unknown. 8 Phase 4.

By phase and status

PhaseTrialsStatus
Phase 48Completed 4, Terminated 2, Not yet recruiting 1, Unknown 1

Follow Teicoplanin: new trials by email Literature Review of Teicoplanin trials Research Report on Teicoplanin

Trials (filtered) newest first · largest first

All 8 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Early Discontinuation of Antibiotics in Paediatric High-risk Febrile Neutropenia
Early Discontinuation of Antibiotics, Standard Antibiotic Continuation Strategy - Febrile Neutropenia (FN), Pediatric Cancer
Phase 4Not yet recruitingHospital Universitari Vall d'Hebron Research Institute1362026-06-012026-05-15
TDM-optimized Teicoplanin Dosing Versus Standard of Care
Teicoplanin - Bacterial Infections
Phase 4TerminatedRadboud University Medical Center542023-08-012026-08-12
Antibiotics Treatment of Cholangitis Post-Kasai Portoenterostomy
Sulperazon, Teicoplanin, Meropenem Injection - Cholangitis, Secondary Biliary, Treatment Compliance
Phase 4CompletedTongji Hospital1602021-05-012022-04-11
Efficacy and Safety of Teicoplanin in CDAD
TEICOPLANIN - Clostridium Difficile Infection-associated Diarrhea and Colitis
Phase 4TerminatedSanofi502020-05-152025-09-23
The Amputation Surgical Site Infection Trial (ASSIT)
Co-amoxiclav, Iodine, Metronidazole - Wound Infection, Amputation Wound
Phase 4CompletedHull University Teaching Hospitals NHS Trust1602013-10-082019-07-15
A Trial to Evaluate the Loading Dose Required to Achieve Therapeutic Serum Teicoplanin Concentration Timely
teicoplanin - Staphylococcal Infections
Phase 4UnknownNational Taiwan University Hospital202006-06-012006-08-24
Comparison of Teicoplanin and Vancomycin in Initial Empirical Antibiotic Regimen for Febrile Neutropenic Patients
Teicoplanin, Vancomycin - Infection, Febrile Neutropenia
Phase 4CompletedSanofi1972005-01-012009-03-06
Teicoplanin Prophylaxis for Total Hip or Knee Arthroplasty
Teicoplanin, β-lactams or ciprofloxacin - Total Hip and Knee Arthroplasties
Phase 4CompletedUniversity of Athens6162004-08-012008-07-21

Conditions studied

Febrile Neutropenia (2)  ·  Infections (2)  ·  Neoplasms (2)  ·  Neutropenia (2)  ·  Bacterial Infections (1)  ·  Biliary Atresia (1)  ·  Cholangitis (1)  ·  Colitis (1)  ·  Fever (1)  ·  Hematologic Neoplasms (1)  ·  Liver Cirrhosis, Biliary (1)  ·  Patient Compliance (1)  ·  Staphylococcal Infections (1)  ·  Surgical Wound Infection (1)  ·  Wound Infection (1)

Sponsors

Sanofi (2)  ·  Hospital Universitari Vall d'Hebron Research Institute (1)  ·  Hull University Teaching Hospitals NHS Trust (1)  ·  National Taiwan University Hospital (1)  ·  Radboud University Medical Center (1)  ·  Tongji Hospital (1)  ·  University of Athens (1)

Countries

China (2)  ·  Greece (1)  ·  Netherlands (1)  ·  Spain (1)  ·  Taiwan (1)  ·  Turkey (Türkiye) (1)  ·  United Kingdom (1)

Top investigators

Amyntas Varvaroussis, MD (1)  ·  Antonios Papadopoulos, MD, PhD (1)  ·  Edibe Taylan (1)  ·  Feng Jiexiong, Postdoctoral (1)  ·  Helen Giamarellou, MD, PhD (1)  ·  Nynke Jager (1)  ·  Panagiotis Papadelis, MD (1)  ·  Shan-Chwen Chang, Ph.D. (1)  ·  Vassilios Nikolaidis, MD (1)

Results publications

PMID 35325055, PMID 37678274

NIH funding

2023 (1)